IDXX IDEXX Laboratories, Inc.

689.65USD-1.26%Mkt Cap: 54.33B USDP/E: 46.47

IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally. It opera…

Insiders, last 90 daysNet sellers
Institutional holders20 on file

Key Statistics

Company
Market Cap54.33B USD
Enterprise Value55.81B USD
Revenue (TTM)4.66B USD
Gross Profit2.66B USD
Net Income (TTM)1.06B USD
Revenue/Share58.77 USD
Last Price689.65 USD
Fiscal Year EndDec 2025
MR QuarterSep 2026
Employees11.0K
CountryUS
SectorHealthcare
IndustryDiagnostics & Research
ISIN—
Valuation
P/E (Trailing)46.47
P/E (Forward)40.82
PEG3.24
EV/EBITDA33.35
EV/Revenue11.97
P/S11.65
P/B29.07
EPS (TTM)14.97 USD
EPS (Forward)16.89 USD
52W Range
500.6170% of range769.98
52W High769.98 USD
52W Low500.61 USD
Profitability
Gross Margin61.80%
Oper. Margin32.50%
EBITDA Margin35.89%
Profit Margin24.62%
ROE65.99%
ROA31.62%
ROIC45.31%
ROCE61.76%
Growth
Revenue Growth9.90%
Earnings Growth17.90%
Cash Flow & Leverage
Operating CF1.18B USD
CapEx (TTM)138.23M USD
FCF Margin22.82%
FCF Yield1.96%
Net Debt775.43M USD
Net Debt/EBITDA0.46
Net Debt/FCF0.73
Balance Sheet
Debt/Equity0.61
Current Ratio1.19
Quick Ratio0.73
Book Value/Sh23.72 USD
Cash/Share2.51 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split2:1
Split DateJun 16, 2015
Analyst Consensus
Rating2.1 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)717.17 USD
Upside (mean)+4.0%
Target Range470.00 USD – 810.00 USD
470.00+4.0% to mean810.00
# Analysts12
Ownership
Shares Out.78.79M
Float78.51M
Insiders0.25%
Institutions95.88%
Short Interest
Short Ratio4.4d
Short % Float3.42%
Short % Out.2.99%
Shares Short2.35M
Short (prev mo.)1.94M
Technical
SMA 50565.71 (+21.9%)
SMA 200572.50 (+20.5%)
Beta1.54
S&P 52W Chg12.08%
Avg Vol (30d)624.79K
Avg Vol (10d)701.09K
Technical Indicators
RSI (14)64.5
MACD37.8279
MACD Signal38.6236
MACD Hist.-0.7957
BB Upper775.03 USD
BB Middle652.90 USD
BB Lower530.77 USD
BB Width37.41%
ATR (14)22.23 USD
Vol Ratio (20d)0.59x

About IDEXX Laboratories (NASDAQ: IDXX)

›

IDEXX Laboratories (NASDAQ: IDXX) is listed on Nasdaq, where its shares trade in USD. It belongs to the Diagnostics & Research industry, part of the Healthcare sector, and reports about 11,000 employees.

The shares were at 689.65 USD on 19 November 2026, down 3.4% over 52 weeks. Its 52-week range is 500.61 USD to 769.98 USD: the price is 10.4% below the high and 37.8% above the low.

At a market capitalisation of 54.33B USD, it trades at 46.5 times trailing earnings and 40.8 times forward earnings. The median trailing P/E of its 18 largest Diagnostics & Research peers is 34.9, a premium of 33% for IDXX.

IDEXX Laboratories reports return on equity of 66.0%, an operating margin of 32.5% and revenue up 9.9% year over year.

Its debt exceeds its cash by 775.43M USD, a debt-to-equity ratio of 0.61. Its Piotroski F-score is 8 out of 9, a strong reading of its financial health. 12 analysts cover the stock, with an average rating of Buy; their mean price target of 717.17 USD is 4.0% above the current price. The next earnings report is expected on 1 February 2027.